Compare EZPW & OCUL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | EZPW | OCUL |
|---|---|---|
| Founded | 1989 | 2006 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Other Specialty Stores | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.0B | 1.9B |
| IPO Year | 1996 | 2014 |
| Metric | EZPW | OCUL |
|---|---|---|
| Price | $32.46 | $10.44 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 3 | 9 |
| Target Price | ★ $30.67 | $23.56 |
| AVG Volume (30 Days) | 974.7K | ★ 2.7M |
| Earning Date | 05-12-2026 | 05-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 29.09 | N/A |
| EPS | ★ 1.65 | N/A |
| Revenue | ★ $747,954,000.00 | $1,990,000.00 |
| Revenue This Year | $25.40 | $7.93 |
| Revenue Next Year | $11.33 | $96.07 |
| P/E Ratio | $20.04 | ★ N/A |
| Revenue Growth | 2.39 | ★ 3.48 |
| 52 Week Low | $16.50 | $6.23 |
| 52 Week High | $37.13 | $16.44 |
| Indicator | EZPW | OCUL |
|---|---|---|
| Relative Strength Index (RSI) | 53.77 | 52.72 |
| Support Level | $31.04 | $10.05 |
| Resistance Level | $36.56 | $10.78 |
| Average True Range (ATR) | 1.56 | 0.50 |
| MACD | 0.05 | -0.03 |
| Stochastic Oscillator | 53.28 | 38.60 |
EZCORP Inc is a United States-based company engaged in offering pawn loans in the United States and Mexico. It also offers short-term unsecured loans and other consumer financial products, and buys and sells second-hand goods. The operating segments of the company are U.S. Pawn, Latin America Pawn, and Other Investments. The U.S. Pawn segment includes all pawn activities in the United States. The Latin America Pawn segment includes all pawn activities in Mexico and other parts of Latin America. The company generates revenue from merchandise sales, jewelry scrapping sales, and pawn service charges, of which key revenue is derived from the merchandise sales, which are mainly collateral forfeited from pawn lending operations and used merchandise purchased from the customers.
Ocular Therapeutix Inc is a biotechnology company that specializes in therapies for diseases and conditions of the eye. The company uses its proprietary hydrogel platform technology to deliver therapeutic agents to the eye. Its pipeline consists of eye medication that aims to overcome the limitations of current eye-drop-based therapies for ophthalmic diseases and conditions. Its pipeline product includes Dextenza, OTX-TIC, OTX-TKI, and OTX-IVT.